1 吕殿红. 广东省养殖场大肠杆菌耐药性调查及多重耐药机制研究. 广州:华南农业大学,2006. 2 陈朝喜. 抗生素压力下大肠杆菌生物被膜模型的建立及相关耐药机制的初步研究. 广州:华南农业大学,2009. 3 陶文琴. 耐FQs大肠杆菌基因突变及检测方法的研究. 广州:华南农业大学,2004. 4 赵明秋, 沈海燕, 潘文,等.细菌耐药性产生的原因、机制及防治措施[J].中国畜牧兽医,2011,38(5):177~181. 5 Chen C, Liao X, Jiang H, et al. Characteristics of Escherichia coli biofilm production, genetic typing, drug resistance pattern and gene expression under aminoglycoside pressures[J]. Environ Toxicol Pharmacol,2010,30(1):5~10. 6 Chen S, Cui S H, Mcdermott P F, et al. Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials[J]. Antimicrob Agents Chemother, 2007,51(2):535~542. 7 Gibson J S, Cobbold R N, Kyaw-Tanner M T, et al. Fluoroquinolone resistance mechanisms in multidrug-resistant Escherichia coli isolated from extraintestinal infections in dogs[J]. Veterinary Microbiology,2010,146:161~166. 8 Hopkins K L, Davies R H, Threlfall E J. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: Recent developments[J]. Int J Antimicrob Agents,2005,25(5):358~373. 9 Heather M, Vinson A G S O. Molecular analysis of porin gene transcription in heterogenotypic multidrug-resistant Escherichia coli isolates from scouring calves[J]. Antimicrob Chemother,2010,65:1926~1935. 10 Komp L P, Karlsson A, Hughes D. Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections[J]. Antimicrob Agents Chemother,2003,47(10):3222~3232. 11 Koutsolioutsou A, Pena-Llopis S, Demple B. Constitutive SoxR mutations contribute to multiple-antibiotic resistance in clinical Escherichia coli isolates[J]. Antimicrob Agents Chemother,2005,49(7):2746~2752. 12 Krapp A R, Humbert M V, Carrillo N. The SoxRS response of Escherichia coli can be induced in the absence of oxidative stress and oxygen by modulation of NADPH content[J]. Microbiology,2011,157(4):957~965. 13 Mark A, Webber M A, Talukder A, et al. ontribution of mutation at amino acid 45 of acrR to acrB expression and ciprofloxacin resistance in clinical and veterinary Escherichia coli isolates[J]. Antimicrob Agents Chemother, 2005,49(10):4390~4392. 14 O’Regan E, Quinn T, Pages J M, et al. Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: Involvement of RamA and other global regulators[J]. Antimicrob Agents Chemother, 2009,53(3):1080~1087. 15 Ruiz J. Mechanisms of resistance to quinolones: Target alterations, decreased accumulation and DNA gyrase protection[J]. J Antimicrob Chemother, 2003,51(5):1109~1117. 16 Ruiz C, Levy S B. Many chromosomal genes modulate MarA-mediated multidrug resistance in Escherichia coli[J]. Antimicrob Agents Chemother, 2010,54(5):2125~2134. 17 Tavío M M, Aquili V D, Poveda J B, et al. Quorum-sensing regulator sdiA and marA overexpression is involved[J]. Journal of Antimicrobial Chemotherapy, 2010,65(6):1178~1186. 18 Wang H, Dzink-Fox J L, Chen M J, et al. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: Role of acrR mutations [J]. Antimicrob Agents Chemother, 2001,45(5):1515~1521. |